title: Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples.
abstract: The novel PGMY L1 consensus primer pair is more sensitive than the MY09 and MY11 primer mix for detection and typing with PCR of human papillomavirus (HPV) DNA in genital specimens. We assessed the diagnostic yield of PGMY primers for the detection and typing of HPV by comparing the results obtained with PGMY09/PGMY11 and MY09/MY11/HMB01 on 299 genital samples. Amplicons generated with PGMY primers were typed with the line blot assay (PGMY-line blot), while HPV amplicons obtained with the degenerate primer pool MY09/MY11/HMB01 were detected with type-specific radiolabeled probes in a dot blot assay (standard consensus PCR test). Cervicovaginal lavage samples (N = 272) and cervical scrape samples (N = 27) were tested in parallel with both PCR tests. The PGMY-line blot test detected the presence of HPV DNA more frequently than the standard consensus PCR assay. The concordance for HPV typing between the two assays was 84.3% (214 of 255 samples), for a good kappa value of 0.69. Of the 177 samples containing HPV DNA by at least one method, 40 samples contained at least one HPV type detected only with PGMY-line blot, whereas positivity exclusively with the standard consensus PCR test was found for only 7 samples (P < 0.001). HPV types 45 and 52 were especially more frequently detected with PGMY than MY primers. However, most HPV types were better amplified with PGMY primers, including HPV-16. Samples with discordant results between the two PCR assays more frequently contained multiple HPV types. Studies using PGMY instead of MY primers have the potential to report higher detection rates of HPV infection not only for newer HPV types but also for well-known genital types.
authors.affiliation: Laboratoire de Virologie Moléculaire, Centre de Recherche et Département de Microbiologie et Infectiologie, Hôpital Notre-Dame du Centre Hospitalier de l'Université de Montréal, Canada. francois.coutlee@ssss.gouv.qc.ca
authors.forename: François
authors.initials: F
authors.lastname: Coutlée
authors.forename: Patti
authors.initials: P
authors.lastname: Gravitt
authors.forename: Janet
authors.initials: J
authors.lastname: Kornegay
authors.forename: Catherine
authors.initials: C
authors.lastname: Hankins
authors.forename: Harriet
authors.initials: H
authors.lastname: Richardson
authors.forename: Normand
authors.initials: N
authors.lastname: Lapointe
authors.forename: Hélène
authors.initials: H
authors.lastname: Voyer
authors.forename: Eduardo
authors.initials: E
authors.lastname: Franco
mesh_terms: D002584:Cervix Uteri / Q000821:virology*; D004279:DNA, Viral / Q000032:analysis*; D005260:Female; D005838:Genotype; D006367:HeLa Cells; D006801:Humans; D027383:Papillomaviridae / Q000235:genetics / Q000302:isolation & purification*; D016133:Polymerase Chain Reaction / Q000379:methods*; D014621:Vagina / Q000821:virology*
chemical_list: D004279:DNA, Viral